-
公开(公告)号:US20230124095A1
公开(公告)日:2023-04-20
申请号:US17909549
申请日:2021-01-28
Applicant: AMORPHICAL LTD.
Inventor: Yossi BEN , Yigal BLUM , Yehudit NATAN
Abstract: The preset invention is directed to ACC particles stabilized by at least one stabilizing agent, a pharmaceutical composition including same, and methods of using same, such as for treating or preventing an acidosis-related disease or condition in a subject in need thereof.
-
公开(公告)号:US20240018009A1
公开(公告)日:2024-01-18
申请号:US18227077
申请日:2023-07-27
Applicant: AMORPHICAL LTD.
Inventor: Yossi BEN , Yigal BLUM , Roni Antoine ILLOS , Ben ASHKENAZI
CPC classification number: C01F5/24 , C01F11/18 , C01G9/00 , A61K33/10 , A61K33/30 , A61K33/42 , C01P2002/02 , A61K9/10 , C01P2004/03 , C01P2004/62 , C01P2004/64 , C01P2006/12 , A61K9/16
Abstract: The present invention provides a composition including a particle, the particle includes a carbonate species of a first divalent metal and carbonate specie of a second divalent metal; wherein the particle is amorphous; wherein the first divalent metal and the second divalent metal are in an oxidation state of +2; and wherein the first divalent metal and the second divalent metal is each independently selected from: Ca, Zn, Fe, Cu, Co, Ni, Mn, Mg and Cr. Further provided is a composition including a divalent metal carbonate including any derivative thereof, and at least one stabilizing agent, wherein the divalent metal is selected from: Zn, Cu, Co, Mn, Mg, and Ni, optionally being characterized by BET between 20 and 200 m2/g. Pharmaceutical or nutraceutical compositions including the composition of particles disclosed, are also provided.
-